Stockscreener 앱 받기
10.33
0.88%
0.09
시간 외 거래:
10.29
-0.04
-0.39%
전일 마감가:
$10.24
열려 있는:
$10.02
하루 거래량:
1.71M
Relative Volume:
0.82
시가총액:
$1.57B
수익:
$177.28M
순이익/손실:
$-195.24M
주가수익비율:
-7.709
EPS:
-1.34
순현금흐름:
$-114.54M
1주 성능:
-3.91%
1개월 성능:
-7.69%
6개월 성능:
+33.29%
1년 성능:
+132.13%
1일 변동 폭
$10.02
$10.45
1주일 범위
$9.9551
$10.85
52주 변동 폭
$3.845
$12.43
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
명칭
Adaptive Biotechnologies Corp
전화
206-659-0067
주소
1165 EASTLAKE AVE E, SEATTLE, WA
ADPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
10.33 | 1.56B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-18 | 개시 | Craig Hallum | Buy |
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-21 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Underperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2022-02-16 | 재확인 | BTIG Research | Buy |
| 2022-02-16 | 재확인 | BofA Securities | Buy |
| 2022-02-16 | 재확인 | Goldman | Neutral |
| 2022-02-16 | 재확인 | JP Morgan | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-03-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 개시 | Goldman | Buy |
| 2019-07-23 | 개시 | BTIG Research | Buy |
| 2019-07-22 | 개시 | BofA/Merrill | Buy |
| 2019-07-22 | 개시 | Cowen | Outperform |
| 2019-07-22 | 개시 | Goldman | Neutral |
| 2019-07-22 | 개시 | Guggenheim | Buy |
| 2019-07-22 | 개시 | William Blair | Outperform |
모두보기
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
What makes Adaptive Biotechnologies Corporation stock price move sharplyLightning-fast capital gains - jammulinksnews.com
Published on: 2025-08-03 02:46:08 - jammulinksnews.com
Should I hold or sell Adaptive Biotechnologies Corporation stock in 2025Expert Picks Tips With Proven Results - jammulinksnews.com
How Adaptive Biotechnologies Corporation stock reacts to Fed policy changesFree Entry and Exit Strategy Optimizer Tool - Newser
When is Adaptive Biotechnologies Corporation stock expected to show significant growthEntry Signal Planner To Watch Now - jammulinksnews.com
Visual trend scoring systems applied to Adaptive Biotechnologies CorporationNext Day Momentum Stock Forecasting Report - Newser
Analyzing recovery setups for Adaptive Biotechnologies Corporation investorsBuy Zone Strategy with Pattern Recognition - Newser
Sentiment Turns Positive on Adaptive Biotechnologies Corporation — Reversal AheadEntry and Exit Strategy Optimizer Tool Tested - metal.it
BTIG Increases Price Target for Adaptive Biotechnologies (ADPT) to $13 - GuruFocus
How Efficient Is Adaptive Biotechnologies Corporation at Controlling Operating CostsPattern Recognition Based Market Move Prediction - Newser
Published on: 2025-07-29 02:45:46 - Newser
Why Adaptive Biotechnologies Corporation stock attracts strong analyst attentionFundamental + Technical Combined Watchlist - Newser
How does Adaptive Biotechnologies Corporation generate profit in a changing economyInvest confidently with real-time data analysis - jammulinksnews.com
Bank of New York Mellon Corp Has $2.66 Million Position in Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World
What catalysts could drive Adaptive Biotechnologies Corporation stock higher in 2025Breakout profit opportunities - jammulinksnews.com
Sectors Driving Future Growth for Adaptive Biotechnologies Corporation StockFree Stock Index Interpretation - Newser
New Product Launches: Will They Boost Adaptive Biotechnologies Corporation Stock in 2025Market Timing Advice - Newser
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics - Benzinga
U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth - GlobeNewswire Inc.
Adaptive Biotechnologies' (NASDAQ:ADPT) investors will be pleased with their strong 161% return over the last year - Yahoo Finance
Victory Capital Management Inc. Has $13.11 Million Holdings in Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World
What analysts say about Adaptive Biotechnologies Corporation stockRecord-breaking capital gains - Autocar Professional
Adaptive Biotechnologies Corporation Stock Analysis and ForecastExplosive trading opportunities - jammulinksnews.com
Is Adaptive Biotechnologies Corporation a good long term investmentExplosive wealth accumulation - jammulinksnews.com
How Adaptive Biotechnologies Corporation stock performs during market volatilityFree Access to Community with 300% Return - Newser
Adaptive Biotechnologies Corporation (ADPT) Rose on Solid Results - Yahoo.co
Principal Financial Group Inc. Purchases 141,691 Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World
Cerity Partners LLC Sells 21,433 Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Teacher Retirement System of Texas Acquires New Position in Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025 - The Manila Times
Adaptive Biotechnologies Corporation to Announce Second Quarter 2025 Financial Results on August 5, 2025 - Quiver Quantitative
Wealth Enhancement Advisory Services LLC Invests $87,000 in Adaptive Biotechnologies Corporation (NASDAQ:ADPT) - Defense World
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year? - Yahoo Finance
Adaptive Biotechnologies and Flatiron Health Collaborate to Integrate clonoSEQ® Test into OncoEMR® for Enhanced Blood Cancer Care - Quiver Quantitative
Adaptive Biotechnologies Corporation(NasdaqGS:ADPT) added to Russell 3000 Growth Index - MarketScreener
Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains? - Yahoo Finance
Craig-Hallum Initiates Coverage of Adaptive Biotechnologies (ADPT) stock, Gives Buy - Insider Monkey
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Cathie Wood's Ark Invest Adds Airbnb, AMD, Shopify To Portfolio, Slashes Stake In Circle Internet - Benzinga
Cathie Wood’s ARK buys BWX stock, sells Adaptive Biotech By Investing.com - Investing.com India
Cathie Wood’s ARK buys BWX stock, sells Adaptive Biotech - Investing.com
Adaptive Biotechnologies Corp (ADPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.15%
자본화:
|
볼륨(24시간):